- Home
- ANGO vs MIY Comparison
ANGO vs MIY Comparison
Compare ANGO & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANGO | MIY |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.2M | 354.5M |
| IPO Year | 2004 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ANGO | MIY |
|---|---|---|
| Price | $10.50 | $12.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 472.7K | 63.3K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $291,010,000.00 | N/A |
| Revenue This Year | $9.11 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.17 | N/A |
| 52 Week Low | $8.36 | $10.57 |
| 52 Week High | $13.99 | $12.90 |
Technical Indicators
Market Signals| Indicator | ANGO | MIY |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 51.60 |
| Support Level | $10.38 | $12.01 |
| Resistance Level | $11.25 | $12.50 |
| Average True Range (ATR) | 0.60 | 0.35 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 42.50 | 67.83 |
Price Performance
Historical ComparisonAbout ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.